RICHMOND MARK 4
4 · OSI PHARMACEUTICALS INC · Filed May 3, 2005
Insider Transaction Report
Form 4
RICHMOND MARK
Director
Transactions
- Sale
Common Stock
2005-05-02$47.47/sh−900$42,723→ 3,575 total - Sale
Common Stock
2005-05-02$47.43/sh−500$23,715→ 4,575 total - Sale
Common Stock
2005-05-02$47.44/sh−100$4,744→ 4,475 total - Exercise/Conversion
Common Stock
2005-05-02$16.81/sh+1,500$25,220→ 5,075 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-05-02−1,500→ 26,000 totalExercise: $16.81From: 2000-04-10Exp: 2010-04-09→ Common Stock (1,500 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Exercisable as to 25,000 shares on 04/10/2000 and the remainder on 04/10/2001.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.